91 related articles for article (PubMed ID: 22169287)
1. [Preliminary establishment of transplanted human chronic myeloid leukemia model in nude mice].
Li XM; Ding X; Zhang LZ; Cen JN; Chen ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1378-82. PubMed ID: 22169287
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of Mouse Model with Humanized Chronic Myeloid Leukemia].
Xu YJ; Jia WH; Liu CC; Chen WR; Li DP; Huang YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1329-1333. PubMed ID: 27784351
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a transplantable human myeloid BALB/c nude mouse model.
Wei YM; Lin JH; Xia R; Lan JC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):596-600. PubMed ID: 16129041
[TBL] [Abstract][Full Text] [Related]
4. [Establishment of a nude mouse model of human monocytic leukemia with multi-organ infiltration].
Li ZJ; Chen ZX; Cen JN; Lu J; He J
Ai Zheng; 2006 Oct; 25(10):1307-10. PubMed ID: 17059783
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a nude mice model of human monocytic leukemia with CNS and multiorgan extramedullary infiltration.
Li Z; Chen Z; Lu J; Cen J; He J; Chen S; Xue Y; Guo L
Eur J Haematol; 2006 Aug; 77(2):128-33. PubMed ID: 16856908
[TBL] [Abstract][Full Text] [Related]
6. Engraftment of chronic myeloid leukemia in SCID mice.
Hoyle CF; Negrin RS
Hematol Oncol; 1998 Sep; 16(3):87-100. PubMed ID: 10235067
[TBL] [Abstract][Full Text] [Related]
7. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.
Sirard C; Lapidot T; Vormoor J; Cashman JD; Doedens M; Murdoch B; Jamal N; Messner H; Addey L; Minden M; Laraya P; Keating A; Eaves A; Lansdorp PM; Eaves CJ; Dick JE
Blood; 1996 Feb; 87(4):1539-48. PubMed ID: 8608245
[TBL] [Abstract][Full Text] [Related]
8. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
Eisterer W; Jiang X; Christ O; Glimm H; Lee KH; Pang E; Lambie K; Shaw G; Holyoake TL; Petzer AL; Auewarakul C; Barnett MJ; Eaves CJ; Eaves AC
Leukemia; 2005 Mar; 19(3):435-41. PubMed ID: 15674418
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model.
Park J; Kim KI; Koh Y; Won NH; Oh JM; Lee DS; Kim BK; Ahn KS; Yoon SS
Exp Hematol; 2010 Sep; 38(9):773-81. PubMed ID: 20438801
[TBL] [Abstract][Full Text] [Related]
10. [Growth and infiltration of human monocytic leukemia cell in nude mice: a model for central nervous system leukemia].
Li ZJ; Chen ZX; Lu J; Cen JN; He J; Guo LC
Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):374-8. PubMed ID: 17147225
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells.
Lewis ID; McDiarmid LA; Samels LM; To LB; Hughes TP
Blood; 1998 Jan; 91(2):630-40. PubMed ID: 9427719
[TBL] [Abstract][Full Text] [Related]
12. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia.
Zhao Z; Tang X; You Y; Li W; Liu F; Zou P
Leuk Res; 2006 Aug; 30(8):993-1003. PubMed ID: 16448696
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
[TBL] [Abstract][Full Text] [Related]
14. [Isolation and identification of chronic myelogenous leukemia bone marrow mesenchymal stem cells and their functional characteristics].
Zhao ZG; Tang XQ; Li J; Shi MX; Zou P
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2054-7. PubMed ID: 16313801
[TBL] [Abstract][Full Text] [Related]
15. Differences between normal and CML stem cells: potential targets for clinical exploitation.
Eaves AC; Barnett MJ; Ponchio L; Cashman JD; Petzer AL; Eaves CJ
Stem Cells; 1998; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
[TBL] [Abstract][Full Text] [Related]
16. Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.
Askmyr M; Ågerstam H; Lilljebjörn H; Hansen N; Karlsson C; von Palffy S; Landberg N; Högberg C; Lassen C; Rissler M; Richter J; Ehinger M; Järås M; Fioretos T
Blood Cancer J; 2014 Dec; 4(12):e269. PubMed ID: 25501026
[TBL] [Abstract][Full Text] [Related]
17. Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation.
Dazzi F; Hasserjian R; Gordon MY; Boecklin F; Cotter F; Corbo M; Capelli D; Goldman JM
Hematol J; 2000; 1(5):307-15. PubMed ID: 11920208
[TBL] [Abstract][Full Text] [Related]
18. Purging efficacy of ZnPcH₁-based photodynamic therapy on chronic myeloid leukemia bone marrow.
Huang H; Chen Y; Chen W; Wu Y
Int J Lab Hematol; 2011 Oct; 33(5):477-82. PubMed ID: 21457188
[TBL] [Abstract][Full Text] [Related]
19. Propagation of human blastic myeloid leukemias in the SCID mouse.
Sawyers CL; Gishizky ML; Quan S; Golde DW; Witte ON
Blood; 1992 Apr; 79(8):2089-98. PubMed ID: 1562735
[TBL] [Abstract][Full Text] [Related]
20. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
